COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers (CHAMPS)
Clara Health

CHAMPS Study of Healthcare, First Responder and Service Workers

Sponsored by Villanova University


The Villanova University Fitzpatrick College of Nursing is launching a study of the experience and health of service staff, first responders and healthcare professionals who provided support for patients and the community during the COVID-19 pandemic. Please consider participating and helping to disseminate information to anyone who may be interested.

The COVID-19 CHAMPS Study is designed to obtain data about working conditions, exposures, health concerns and well-being of individuals in a broad range of occupations.

About 
COVID-19

Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

Study type: Observational [Patient Registry] Estimated Enrollment: 20000 participants Official Title: Registry to Study Factors That May Impact COVID-19 Occurrence and Severity Estimated Study Start Date: April 27, 2020 Estimated Study Completion Date: April 27, 2040

Who is this study for?

Study Population Any adult exposed to increased risk of infection by SARS-CoV-2 as a result of work in the community or in settings where COVID-19 patients are screened, diagnosed or receive care.

Included are first responders (e.g., police officers, firefighters, emergency medical technicians, paramedics) service employees (office staff, maintenance, housekeeping, food service), and healthcare professionals (e.g., physicians, nurses, phlebotomists, respiratory therapists, pharmacists).

What should I expect?

  • No direct health benefits are anticipated for participating in the study, but participants may learn about their health.
  • Participation in the study provides the participants the opportunity to express the impact of responding to the COVID-19 pandemic on their health, which may be a source of relief.
  • Participants may feel satisfaction about sharing information about their experiences that may help healthcare systems to plan for future health-related emergencies.

Have a question?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you’ll be connected to the study team.